PMID- 27760342 OWN - NLM STAT- MEDLINE DCOM- 20170905 LR - 20181113 IS - 1097-4180 (Electronic) IS - 1074-7613 (Print) IS - 1074-7613 (Linking) VI - 45 IP - 4 DP - 2016 Oct 18 TI - Antiviral CD8(+) T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion. PG - 917-930 LID - S1074-7613(16)30384-3 [pii] LID - 10.1016/j.immuni.2016.09.015 [doi] AB - CD8(+) T cell recognition of virus-infected cells is characteristically restricted by major histocompatibility complex (MHC) class I, although rare examples of MHC class II restriction have been reported in Cd4-deficient mice and a macaque SIV vaccine trial using a recombinant cytomegalovirus vector. Here, we demonstrate the presence of human leukocyte antigen (HLA) class II-restricted CD8(+) T cell responses with antiviral properties in a small subset of HIV-infected individuals. In these individuals, T cell receptor beta (TCRbeta) analysis revealed that class II-restricted CD8(+) T cells underwent clonal expansion and mediated killing of HIV-infected cells. In one case, these cells comprised 12% of circulating CD8(+) T cells, and TCRalpha analysis revealed two distinct co-expressed TCRalpha chains, with only one contributing to binding of the class II HLA-peptide complex. These data indicate that class II-restricted CD8(+) T cell responses can exist in a chronic human viral infection, and may contribute to immune control. CI - Copyright (c) 2016 The Author(s). Published by Elsevier Inc. All rights reserved. FAU - Ranasinghe, Srinika AU - Ranasinghe S AD - Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA. Electronic address: sranasinghe@mgh.harvard.edu. FAU - Lamothe, Pedro A AU - Lamothe PA AD - Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA; Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. FAU - Soghoian, Damien Z AU - Soghoian DZ AD - Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA. FAU - Kazer, Samuel W AU - Kazer SW AD - Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 01239, USA; Broad Institute, Cambridge, MA 01239, USA. FAU - Cole, Michael B AU - Cole MB AD - Department of Physics, University of California, Berkeley, CA 94720, USA. FAU - Shalek, Alex K AU - Shalek AK AD - Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 01239, USA; Broad Institute, Cambridge, MA 01239, USA. FAU - Yosef, Nir AU - Yosef N AD - Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA; Department of Physics, University of California, Berkeley, CA 94720, USA. FAU - Jones, R Brad AU - Jones RB AD - Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA; George Washington University, Washington, DC 20052, USA. FAU - Donaghey, Faith AU - Donaghey F AD - Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA. FAU - Nwonu, Chioma AU - Nwonu C AD - Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA. FAU - Jani, Priya AU - Jani P AD - Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA. FAU - Clayton, Gina M AU - Clayton GM AD - Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA; Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA. FAU - Crawford, Frances AU - Crawford F AD - Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA; Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA. FAU - White, Janice AU - White J AD - Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA. FAU - Montoya, Alana AU - Montoya A AD - Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA. FAU - Power, Karen AU - Power K AD - Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA. FAU - Allen, Todd M AU - Allen TM AD - Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA. FAU - Streeck, Hendrik AU - Streeck H AD - Institute for HIV Research, University Hospital, University Duisburg-Essen, Essen 45147, Germany; U.S. Military HIV Research Program, Henry M. Jackson Foundation, Rockville, MD 20910, USA. FAU - Kaufmann, Daniel E AU - Kaufmann DE AD - Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA; Centre de Recherche du Centre hospitalier de l'Universite de Montreal, Montreal, QC H2X 3J4, Canada. FAU - Picker, Louis J AU - Picker LJ AD - Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA. FAU - Kappler, John W AU - Kappler JW AD - Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA; Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA. FAU - Walker, Bruce D AU - Walker BD AD - Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 01239, USA; Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 01239, USA; Broad Institute, Cambridge, MA 01239, USA. Electronic address: bwalker@mgh.harvard.edu. LA - eng GR - DP2 GM119419/GM/NIGMS NIH HHS/United States GR - P01 AI104715/AI/NIAID NIH HHS/United States GR - U24 AI118672/AI/NIAID NIH HHS/United States GR - R21 AI125085/AI/NIAID NIH HHS/United States GR - P30 AI060354/AI/NIAID NIH HHS/United States GR - HHMI/Howard Hughes Medical Institute/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PL - United States TA - Immunity JT - Immunity JID - 9432918 RN - 0 (Antiviral Agents) RN - 0 (HLA Antigens) RN - 0 (Histocompatibility Antigens Class II) RN - 0 (Receptors, Antigen, T-Cell, alpha-beta) SB - IM CIN - Immunity. 2016 Oct 18;45(4):712-714. PMID: 27760334 MH - Antiviral Agents/*immunology MH - CD8-Positive T-Lymphocytes/*immunology MH - HIV Infections/*immunology MH - HLA Antigens/immunology MH - Histocompatibility Antigens Class II/*immunology MH - Humans MH - Receptors, Antigen, T-Cell, alpha-beta/*immunology PMC - PMC5077698 OTO - NOTNLM OT - CD8(+) T cells OT - HIV OT - HLA OT - MHC class II OT - TCR OT - vaccines EDAT- 2016/10/21 06:00 MHDA- 2017/09/07 06:00 PMCR- 2016/10/18 CRDT- 2016/10/21 06:00 PHST- 2016/06/03 00:00 [received] PHST- 2016/08/09 00:00 [revised] PHST- 2016/08/15 00:00 [accepted] PHST- 2016/10/21 06:00 [pubmed] PHST- 2017/09/07 06:00 [medline] PHST- 2016/10/21 06:00 [entrez] PHST- 2016/10/18 00:00 [pmc-release] AID - S1074-7613(16)30384-3 [pii] AID - 10.1016/j.immuni.2016.09.015 [doi] PST - ppublish SO - Immunity. 2016 Oct 18;45(4):917-930. doi: 10.1016/j.immuni.2016.09.015.